Antidiabetic Activity of Artemisia amygdalina Decne in Streptozotocin Induced Diabetic Rats

Table 3

Effect of extracts of Artemisia amygdalina and glibenclamideon liver marker enzymes of streptozotocin induced diabetic rats.

Groups	SGOT (U/L)	SGPT (U/L)	ALP (U/L)
Normal	115.00±5.14	95.23±6.75	175.67±8.68
Diabetic control	243.00±9.57	209.16±6.35	296.17±7.85
Hydroethanolic extract (250 mg/kg b. w)	164.31±6.53	148.76±7.69	232.17±6.82
Hydroethanolic extract (500 mg/kg b. w)	129.66±8.08^∗∗	112.83±7.11^∗∗	201.66±7.94^∗∗
Methanolic extract (250 mg/kg b. w)	174.76±4.83	177.62±7.71	229.77±6.18
Methanolic extract (500 mg/kg b. w)	138.53±2.94^∗∗	121.85±6.69^∗∗	219.53±7.37
Glibenclamide (3 mg/kg b. w)	119.50±4.43^∗∗	103.73±3.00^∗∗	198.50±7.14^∗∗

The values are expressed as mean ± SEM; 𝑛=5 in each group. ^∗∗𝑃<0.01 as compared with diabetic control at the same time (one-way ANOVA followed by Dunnett’s multiple comparison test).